Anders Neijber
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Impact of Photodynamic Diagnosis on Immune Cell Infiltration in BCG-treated Non-muscle-invasive Bladder Cancer.
Journal: European urology open science
Published: July 16, 2026
Immune Contexture Changes Following Blue Light Cystoscopy with Hexaminolevulinate in Bladder Cancer.
Immune Contexture Changes Following Blue Light Cystoscopy with Hexaminolevulinate in Bladder Cancer.
Journal: European urology open science
Published: October 16, 2023
A new 2% testosterone gel formulation: a comparison with currently available topical preparations.
Journal: Andrology
Published: December 18, 2017
EFFICACY AND SAFETY OF A NEW TOPICAL TESTOSTERONE REPLACEMENT GEL THERAPY FOR THE TREATMENT OF MALE HYPOGONADISM.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: February 23, 2017
The efficacy, bioavailability and safety of a novel hydroalcoholic testosterone gel 2% in hypogonadal men: results from phase II open-label studies.
Journal: Andrologia
Published: September 07, 2015
Factors Predicting the Off-treatment Duration in Patients with Prostate Cancer Receiving Degarelix as Intermittent Androgen Deprivation Therapy.
Journal: European urology focus
Published: August 27, 2015
Degarelix Versus Goserelin Plus Bicalutamide in the Short-Term Relief of Lower Urinary Tract Symptoms in Prostate Cancer Patients: Results of a Pooled Analysis.
Journal: Lower urinary tract symptoms
Published: February 26, 2015
Pharmacokinetics and bioavailability of a new testosterone gel formulation in comparison to Testogel® in healthy men.
Journal: Clinical pharmacology in drug development
Published: July 03, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026